Emily L. is a Senior Scientist at Merck, where they focus on preclinical development in the field of precision medicine, particularly aiming to enhance cancer patient outcomes. Emily completed their PhD in Molecular Medicine from The George Washington University and gained significant experience as a Graduate Student Researcher at the National Institutes of Health, where they specialized in autologous cellular immunotherapy for blood cancers. Previous roles include a Postdoctoral Researcher position at the National Institutes of Health and a Research Technician at Memorial Sloan-Kettering Cancer Center, among others. Emily’s academic background includes a B.S. in Neuroscience and Biology from Brandeis University, where they also participated in several impactful research projects.
This person is not in the org chart
This person is not in any teams
This person is not in any offices